Calgranulin B (MRP‐14) in urine has emerged as a possible marker of prostate cancer, first identified by Rehman et al.45 A gel‐based proteomic method was used to evaluate 12 urine samples from patients with prostate cancer or benign prostatic hyperplasia. The gene discussed is S100A9; the disease is benign prostatic hyperplasia.